ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

ClinicalTrials.gov ID: NCT02791230

Public ClinicalTrials.gov record NCT02791230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3 MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826-83) 20 MG OR 80 MG [OR TAFAMIDIS (PF-06291826-00) 61 MG] IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (ATTR-CM)

Study identification

NCT ID
NCT02791230
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,733 participants

Conditions and interventions

Interventions

  • Tafamidis Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 12, 2016
Primary completion
Oct 25, 2023
Completion
Nov 1, 2023
Last update posted
Feb 2, 2025

2016 – 2023

United States locations

U.S. sites
41
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
The Kirklin Clinic of UAB Hospital Birmingham Alabama 35233
Cardiovascular Clinical Trials Unit (CCTU) Birmingham Alabama 35294
University Hospital, University of Alabama at Birmingham Birmingham Alabama 35294
California Heart Center Beverly Hills California 90211
Cedars-Sinai Medical Care Foundation Beverly Hills California 90211
Altman Clinical Translational Research Institute La Jolla California 92037
University of California, San Diego La Jolla California 92037
Cedars-Sinai Medical Center Los Angeles California 90048
University of California, San Diego Medical Center - Hillcrest San Diego California 92103
Center Adv Lab Medicine San Diego California 92121
UCSF Ambulatory Care Center San Francisco California 94143
University of California San Francisco California 94143
UCSF Cardiovascular Care and Prevention Center San Francisco California 94158
Stanford University Hospital and Clinics Stanford California 94305
Sylvester at Deerfield Beach Deerfield Beach Florida 33136
University of Miami Hospital & Clinics/Sylvester Comprehensive Cancer Center Miami Florida 33136
Northwestern Medical Group Chicago Illinois 60611
Northwestern Memorial Hospital Chicago Illinois 60611
Advocate Christ Medical Center Oak Lawn Illinois 60453
University of Maryland, Baltimore Baltimore Maryland 21201
Johns Hopkins University Baltimore Maryland 21287
Boston Medical Center Investigational Pharmacy Boston Massachusetts 02118
Boston Medical Center Boston Massachusetts 02118
Boston University Medical Center Boston Massachusetts 02118
Michigan Medicine,University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Hospital-Rochester Rochester Minnesota 55902
Mayo Clinic Rochester Minnesota 55905
Newark Beth Israel Medical Center Newark New Jersey 07112
NYU Langone Health New York New York 10016
Center for Advanced Cardiac Care New York New York 10032
Columbia University Irving Medical Center New York New York 10032
Duke University Durham North Carolina 27710
Cleveland Clinic Cleveland Ohio 44195
OHSU Center for Health and Healing Portland Oregon 97239
OHSU Research Pharmacy Services Portland Oregon 97239
Oregon Health & Science University Portland Oregon 97239
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104
Vanderbilt Univ. Med. Ctr Nashville Tennessee 37232
Huntsman Cancer Hospital Salt Lake City Utah 84112
University of Utah Hospitals & Clinics Salt Lake City Utah 84132
University of Utah, Division of Cardiovascular Medicine Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02791230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02791230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →